European Archives - Page 23 of 1530 - European Medical Journal

People Experiencing Homelessness to Be Offered Flu Jabs on NHS

People experiencing homelessness are to be offered free flu vaccinations on the NHS later this year, following advice from the Joint Committee on Vaccination and Immunisation.

CNS neurodegenerative disease BBB

Engineered Antibody Technology Boosts Brain Drug Delivery

Engineered antibody shuttles improve brain delivery of RNA therapies by targeting BBB transport pathways, offering new CNS treatment possibilities.

Flamingo Pharma UK Ltd recalls flucloxacillin capsules

Flamingo Pharma UK Ltd has notified the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect patient information leaflet.

stem cell transplantation

Stem Cell Transplantation Most Cost-Effective in Sickle Cell Disease

Stem cell transplantation has been found to be the most cost-effective option for the long-term care of sickle cell disease in adults in the USA.

EHA Congress Wrap

The European Hematology Association (EHA) Congress 2026 brought together haematology experts from around the world to share the latest…

Focus on Moderate-to-Severe AD Including Face and Neck Involvement

Listen to experts Stephan Weidinger and Christian Vestergaard discuss rapid and sustained disease control in moderate-to-severe atopic…

Aficamten Improves Hypertrophic Cardiomyopathy Exercise Performance

New evidence suggests Aficamten improves exercise performance compared with Metoprolol in patients with obstructive hypertrophic cardiomyopathy.

Study Reveals Predictors of Severe Respiratory Disease in Children

Children hospitalised with acute respiratory tract infections were more likely to develop severe disease if they had multiple chronic conditions or required transfer from another hospital.

Treating Hearing Loss Lowers Dementia Risk in Epilepsy: EAN 2026

Treating Hearing Loss Lowers Dementia Risk in Epilepsy: EAN 2026

Research presented at EAN 2026 finds hearing aids may cut dementia risk in people with epilepsy and hearing loss, a benefit specific to that group.

Previous Norovirus Exposure May Shape Vaccine Responses

Immune imprinting from earlier norovirus infections may influence how older adults respond to vaccination, according to new research.